The DOI matches its Crossref record; 117 of the 117 references it cites were found in a registry or an index.
Mendelian randomization: where are we now and where are we going?
Open accessAbstract
The methodology and application of Mendelian randomization to study causal mechanisms in health and disease has developed dramatically over the past decade. New methods, large-scale genome-wide analyses, molecular epigenetics and other new -omics technologies are all providing exceptional opportunities for the exploitation of Mendelian randomization approaches to understand causes of complex traits and disease outcomes. This research has the potential to identify new approaches for the prevention and treatment of common conditions. The origins of what is now termed ‘Mendelian randomization’ (Figure 1, see caption for assumptions) can be traced back over half a century,1 although the first extended presentation of the principles was in this journal just over a decade ago,2 Since then it has become a widely utilized methodology, with publications covering many branches of biomarker,3–12 behavioural13–16 and infectious disease17,18 epidemiology. Mendelian randomization studies with clear implications for pharmacotherapeutics are also becoming commonplace,19–21 and applications to social science and to economics (the field in which the statistical technique of instrumental variables analysis central to Mendelian randomization was initially conceived22) are being developed.23,24 Mendelian randomization: using genetic variants as instrumental variables to establish whether an exposure is causally related to a disease or trait. (A) The genotype acts as an instrumental variable if: (i) it is associated with the exposure; (ii) it is independent of measured or unmeasured confounders; and (iii) it can only influence that outcome via the causal effect of the exposure. (B) Under the instrumental variable assumptions, the lack of association between the C-reactive protein genotype and disease risk indicates that C-reactive protein is not a causal risk factor for ischaemic heart disease. An association between the genotype and disease outcome would indicate a causal relationship of the exposure on the outcome. Over the past few years, several methodological advances have been made. The basic assumption—that genetic variants which can proxy for a potentially modifiable exposure are essentially unrelated to confounding factors—has been demonstrated to have widespread plausibility.25 The connection between the standard Mendelian randomization experiment and the theory of instrumental variables has been elaborated upon.26,27 Extensions to use multiple genetic variants for increasing power and investigating the influence of pleiotropy have been theorized28 and implemented.29–32 Bidirectional Mendelian randomization for informing the direction of causal effects has been exemplified33,34 and extended to consider more complex networks.35 Methods for the estimation of non-linear causal effects have been proposed.36,37 Causal effects of related phenotypes with common genetic predictors in a multivariable analysis framework have been estimated.38,39 Factorial Mendelian randomization to predict the separate and combined effect of treatments using different genetic proxies has been undertaken.40 Sensitivity analyses for investigating the biasing effects of pleiotropy have been developed.41,42 Extensions to consider gene-by-environment interactions have been outlined and applied.43–45 The integration of epigenetic profiles as an intermediate phenotype has been proposed46,47 and implemented.48,49 The development of Mendelian randomization into the hypothesis-free resolution of causal directions in correlated networks has been outlined.50 In summary, methodological development has been undertaken in response to the challenges of new substantive applied questions and increasingly detailed genetic data. This development has enabled (and continues to enable) more sophisticated questions to be answered using the framework of Mendelian randomization. Initial applications of Mendelian randomization generally incorporated a single genetic variant, and assessed the causal relationship of the modifiable intermediate phenotype on the outcome in a single sample. The proliferation of genome-wide association study (GWAS) data, and in particular publicly available GWAS data51 (such as summary genetic associations with coronary artery disease in over 60 000 cases and 130 000 controls from the CARDIoGRAMplusC4D consortium52) provides opportunities to extend this via the use of the following. Increased sample sizes. Consortia with GWAS data on large sample sizes are available for many phenotypic traits and disease outcomes. This increases the power of Mendelian randomization investigations.53 Multiple genetic variants. For many intermediate phenotypes investigated in Mendelian randomization studies, GWAS investigations have been able to identify multiple genetic variants contributing to variation in the phenotype. Again, this increases the power of Mendelian randomization investigations.54 Two-sample Mendelian randomization. The ideal context for the pre
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bowden, J., Davey Smith, G., & Burgess, S. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyv080 · Cited by 9,816 · cited 2×
“ment of novel statistical tools for detecting and adjusting for pleiotropy from multiple genetic variants.(41)”
BackgroundMethodSelf-citationMendelian Randomization Analysis With Multiple Genetic Variants Using Summarized Data
Burgess, S., Butterworth, A., & Thompson, S. G. (2013) · Genetic Epidemiology · doi:10.1002/gepi.21758 · Cited by 6,050
Self-citationDavey Smith, G., & Ebrahim, S. (2003) · International Journal of Epidemiology · doi:10.1093/ije/dyg070 · Cited by 5,882
Self-citationGut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Wang, Z., Klipfell, E., Bennett, B. J., Koeth, R., Levison, B. S., DuGar, B., Feldstein, A. E., Britt, E. B., Fu, X., Chung, Y.-M., et al. (2011) · Nature · doi:10.1038/nature09922 · Cited by 5,597
Mendelian randomization: genetic anchors for causal inference in epidemiological studies
Davey Smith, G., & Hemani, G. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu328 · Cited by 4,677
Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology
Lawlor, D. A., Harbord, R. M., Sterne, J. A. C., Timpson, N., & Davey Smith, G. (2008) · Statistics in Medicine · doi:10.1002/sim.3034 · Cited by 4,618
Self-citationAn atlas of genetic correlations across human diseases and traits
ReproGen Consortium, Bulik-Sullivan, B., Psychiatric Genomics Consortium, Genetic Consortium for Anorexia Nervosa of the Wellcome Trust Case Control Consortium 3, Finucane, H. K., Anttila, V., Gusev, A., Day, F. R., Loh, P.-R., Duncan, L., et al. (2015) · Nature Genetics · doi:10.1038/ng.3406 · Cited by 4,255
Metabolite profiles and the risk of developing diabetes
Wang, T. J., Larson, M. G., Vasan, R. S., Cheng, S., Rhee, E. P., McCabe, E., Lewis, G. D., Fox, C. S., Jacques, P. F., Fernandez, C., et al. (2011) · Nature Medicine · doi:10.1038/nm.2307 · Cited by 3,143
Metabolomics: the apogee of the omics trilogy
Patti, G. J., Yanes, O., & Siuzdak, G. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3314 · Cited by 2,571
Angrist, J. D., & Krueger, A. B. (2001) · Journal of Economic Perspectives · doi:10.1257/jep.15.4.69 · Cited by 2,355
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk
The International Consortium for Blood Pressure Genome-Wide Association Studies (2011) · Nature · doi:10.1038/nature10405 · Cited by 2,033
Effects of dalcetrapib in patients with a recent acute coronary syndrome
Schwartz, G. G., Olsson, A. G., Abt, M., Ballantyne, C. M., Barter, P. J., Brumm, J., Chaitman, B. R., Holme, I. M., Kallend, D., Leiter, L. A., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1206797 · Cited by 2,022 · cited 1×
“Genetic variants in the CETP gene region have been used as proxies for cholesterylester transfer protein (CETP) inhibitors, such as dalcetrapib.(92) These drugs are developed to raise high-density lipoprotein cholesterol levels.”
MethodPierce, B. L., Ahsan, H., & VanderWeele, T. J. (2011) · International Journal of Epidemiology · doi:10.1093/ije/dyq151 · Cited by 1,836
EPIC- InterAct Consortium, Burgess, S., Scott, R. A., Timpson, N. J., Davey Smith, G., & Thompson, S. G. (2015) · European Journal of Epidemiology · doi:10.1007/s10654-015-0011-z · Cited by 1,803
Self-citationLarge-scale association analysis identifies new risk loci for coronary artery disease
The CARDIoGRAMplusC4D Consortium, Deloukas, P., DIAGRAM Consortium, CARDIOGENICS Consortium, MuTHER Consortium, Wellcome Trust Case Control Consortium, Kanoni, S., Willenborg, C., Farrall, M., Assimes, T. L., et al. (2013) · Nature Genetics · doi:10.1038/ng.2480 · Cited by 1,614
Burgess, S., & Thompson, S. G. (2015) · American Journal of Epidemiology · doi:10.1093/aje/kwu283 · Cited by 1,605
Self-citationPierce, B. L., & Burgess, S. (2013) · American Journal of Epidemiology · doi:10.1093/aje/kwt084 · Cited by 1,389
Self-citationUsing multiple genetic variants as instrumental variables for modifiable risk factors
Palmer, T. M., Lawlor, D. A., Harbord, R. M., Sheehan, N. A., Tobias, J. H., Timpson, N. J., Smith, G. D., & Sterne, J. A. (2012) · Statistical Methods in Medical Research · doi:10.1177/0962280210394459 · Cited by 1,289
(2012) · The Lancet · doi:10.1016/s0140-6736(12)60110-x · Cited by 1,146
Human metabolic phenotype diversity and its association with diet and blood pressure
Holmes, E., Loo, R. L., Stamler, J., Bictash, M., Yap, I. K. S., Chan, Q., Ebbels, T., De Iorio, M., Brown, I. J., Veselkov, K. A., et al. (2008) · Nature · doi:10.1038/nature06882 · Cited by 1,054
Burgess, S., Dudbridge, F., & Thompson, S. G. (2015) · American Journal of Epidemiology · doi:10.1093/aje/kwv017 · Cited by 934
Self-citationMendelian randomization as an instrumental variable approach to causal inference
Didelez, V., & Sheehan, N. (2007) · Statistical Methods in Medical Research · doi:10.1177/0962280206077743 · Cited by 923
Genetically elevated C-reactive protein and ischemic vascular disease
Zacho, J., Tybjærg-Hansen, A., Jensen, J. S., Grande, P., Sillesen, H., & Nordestgaard, B. G. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707402 · Cited by 839
GWAS of 126,559 Individuals Identifies Genetic Variants Associated with Educational Attainment
Rietveld, C. A., Medland, S. E., Derringer, J., Yang, J., Esko, T., Martin, N. W., Westra, H.-J., Shakhbazov, K., Abdellaoui, A., Agrawal, A., et al. (2013) · Science · doi:10.1126/science.1235488 · Cited by 827
Self-citation(2012) · The Lancet · doi:10.1016/s0140-6736(11)61931-4 · Cited by 823
Swerdlow, D. I., Preiss, D., Kuchenbaecker, K. B., Holmes, M. V., Engmann, J. E. L., Shah, T., Sofat, R., Stender, S., Johnson, P. C. D., Scott, R. A., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61183-1 · Cited by 680
Self-citationC Reactive Protein Coronary Heart Disease Genetics Collaboration (CCGC) (2011) · BMJ · doi:10.1136/bmj.d548 · Cited by 642
Davies, M. N., Volta, M., Pidsley, R., Lunnon, K., Dixit, A., Lovestone, S., Coarfa, C., Harris, R. A., Milosavljevic, A., Troakes, C., et al. (2012) · Genome Biology · doi:10.1186/gb-2012-13-6-r43 · Cited by 630
DNA methylation signatures link prenatal famine exposure to growth and metabolism
Tobi, E. W., Goeman, J. J., Monajemi, R., Gu, H., Putter, H., Zhang, Y., Slieker, R. C., Stok, A. P., Thijssen, P. E., Müller, F., et al. (2014) · Nature Communications · doi:10.1038/ncomms6592 · Cited by 630
Mendelian randomization studies: a review of the approaches used and the quality of reporting
Boef, A. G. C., Dekkers, O. M., & le Cessie, S. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyv071 · Cited by 610
Smith, G. D., Lawlor, D. A., Harbord, R., Timpson, N., Day, I., & Ebrahim, S. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040352 · Cited by 569
Self-citationRelton, C. L., & Davey Smith, G. (2012) · International Journal of Epidemiology · doi:10.1093/ije/dyr233 · Cited by 567
Methodological Challenges in Mendelian Randomization
VanderWeele, T. J., Tchetgen Tchetgen, E. J., Cornelis, M., & Kraft, P. (2014) · Epidemiology · doi:10.1097/ede.0000000000000081 · Cited by 555
Genome-wide association study identifies multiple loci influencing human serum metabolite levels
Kettunen, J., Tukiainen, T., Sarin, A.-P., Ortega-Alonso, A., Tikkanen, E., Lyytikäinen, L.-P., Kangas, A. J., Soininen, P., Würtz, P., Silander, K., et al. (2012) · Nature Genetics · doi:10.1038/ng.1073 · Cited by 553
Anti-inflammatory therapies for cardiovascular disease
Ridker, P. M., & Luscher, T. F. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu203 · Cited by 550
Burgess, S., Daniel, R. M., Butterworth, A. S., Thompson, S. G., & the EPIC-InterAct Consortium (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyu176 · Cited by 543
Self-citationBots, M. L., Visseren, F. L., Evans, G. W., Riley, W. A., Revkin, J. H., Tegeler, C. H., Shear, C. L., Duggan, W. T., Vicari, R. M., Grobbee, D. E., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61088-5 · Cited by 461
Use of allele scores as instrumental variables for Mendelian randomization
Burgess, S., & Thompson, S. G. (2013) · International Journal of Epidemiology · doi:10.1093/ije/dyt093 · Cited by 452
Self-citationFerence, B. A., Majeed, F., Penumetcha, R., Flack, J. M., & Brook, R. D. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.02.020 · Cited by 407
Mendelian Randomisation and Causal Inference in Observational Epidemiology
Sheehan, N. A., Didelez, V., Burton, P. R., & Tobin, M. D. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050177 · Cited by 372
Palmer, T. M., Sterne, J. A. C., Harbord, R. M., Lawlor, D. A., Sheehan, N. A., Meng, S., Granell, R., Smith, G. D., & Didelez, V. (2011) · American Journal of Epidemiology · doi:10.1093/aje/kwr026 · Cited by 325
Timpson, N. J., Nordestgaard, B. G., Harbord, R. M., Zacho, J., Frayling, T. M., Tybjærg-Hansen, A., & Davey Smith, G. (2011) · International Journal of Obesity · doi:10.1038/ijo.2010.137 · Cited by 310
Self-citationScott, J. A. G., Berkley, J. A., Mwangi, I., Ochola, L., Uyoga, S., Macharia, A., Ndila, C., Lowe, B. S., Mwarumba, S., Bauni, E., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60888-x · Cited by 294
Glymour, M. M., Tchetgen Tchetgen, E. J., & Robins, J. M. (2012) · American Journal of Epidemiology · doi:10.1093/aje/kwr323 · Cited by 292
Palmer, T. M., Nordestgaard, B. G., Benn, M., Tybjaerg-Hansen, A., Davey Smith, G., Lawlor, D. A., & Timpson, N. J. (2013) · BMJ · doi:10.1136/bmj.f4262 · Cited by 282
Self-citationWürtz, P., Wang, Q., Kangas, A. J., Richmond, R. C., Skarp, J., Tiainen, M., Tynkkynen, T., Soininen, P., Havulinna, A. S., Kaakinen, M., et al. (2014) · PLoS Medicine · doi:10.1371/journal.pmed.1001765 · Cited by 280
Self-citationNordestgaard, B. G., Palmer, T. M., Benn, M., Zacho, J., Tybjærg-Hansen, A., Davey Smith, G., & Timpson, N. J. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001212 · Cited by 280
Self-citationHingorani, A., & Humphries, S. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67767-7 · Cited by 277
Genetically Determined Height and Coronary Artery Disease
Nelson, C. P., Hamby, S. E., Saleheen, D., Hopewell, J. C., Zeng, L., Assimes, T. L., Kanoni, S., Willenborg, C., Burgess, S., Amouyel, P., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1404881 · Cited by 262
Self-citationRelton, C. L., & Davey Smith, G. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000356 · Cited by 254
Smith, J. G., Luk, K., Schulz, C.-A., Engert, J. C., Do, R., Hindy, G., Rukh, G., Dufresne, L., Almgren, P., Owens, D. S., et al. (2014) · JAMA · doi:10.1001/jama.2014.13959 · Cited by 238
Nitsch, D., Molokhia, M., Smeeth, L., DeStavola, B. L., Whittaker, J. C., & Leon, D. A. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj062 · Cited by 227
Holmes, M. V., Lange, L. A., Palmer, T., Lanktree, M. B., North, K. E., Almoguera, B., Buxbaum, S., Chandrupatla, H. R., Elbers, C. C., Guo, Y., et al. (2014) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.12.014 · Cited by 216
An epigenome-wide association study of total serum immunoglobulin E concentration
Liang, L., Willis-Owen, S. A. G., Laprise, C., Wong, K. C. C., Davies, G. A., Hudson, T. J., Binia, A., Hopkin, J. M., Yang, I. V., Grundberg, E., et al. (2015) · Nature · doi:10.1038/nature14125 · Cited by 213
Clarke, R., Bennett, D. A., Parish, S., Verhoef, P., Dötsch-Klerk, M., Lathrop, M., Xu, P., Nordestgaard, B. G., Holm, H., Hopewell, J. C., et al. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001177 · Cited by 206
Instrumental Variable Analysis with a Nonlinear Exposure–Outcome Relationship
Burgess, S., Davies, N. M., & Thompson, S. G. (2014) · Epidemiology · doi:10.1097/ede.0000000000000161 · Cited by 205
Self-citationMurakami, M., & Kudo, I. (2004) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.27.1158 · Cited by 198
Kamstrup, P. R., Tybjærg-Hansen, A., & Nordestgaard, B. G. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.112.248765 · Cited by 194
Smith, G. D. (2010) · Perspectives on Psychological Science · doi:10.1177/1745691610383505 · Cited by 190
Nordestgaard, A. T., Thomsen, M., & Nordestgaard, B. G. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyv083 · Cited by 189
Timpson, N. J., Harbord, R., Davey Smith, G., Zacho, J., Tybjærg-Hansen, A., & Nordestgaard, B. G. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.130005 · Cited by 187
Self-citationPower and sample size calculations for Mendelian randomization studies using one genetic instrument
Freeman, G., Cowling, B. J., & Schooling, C. M. (2013) · International Journal of Epidemiology · doi:10.1093/ije/dyt110 · Cited by 183
DNA Methylation as a Long-term Biomarker of Exposure to Tobacco Smoke
Shenker, N. S., Ueland, P. M., Polidoro, S., van Veldhoven, K., Ricceri, F., Brown, R., Flanagan, J. M., & Vineis, P. (2013) · Epidemiology · doi:10.1097/ede.0b013e31829d5cb3 · Cited by 179
Chadeau-Hyam, M., Athersuch, T. J., Keun, H. C., De Iorio, M., Ebbels, T. M. D., Jenab, M., Sacerdote, C., Bruce, S. J., Holmes, E., & Vineis, P. (2011) · Biomarkers · doi:10.3109/1354750x.2010.533285 · Cited by 173
Richmond, R. C., Davey Smith, G., Ness, A. R., den Hoed, M., McMahon, G., & Timpson, N. J. (2014) · PLoS Medicine · doi:10.1371/journal.pmed.1001618 · Cited by 167
Self-citationLow-Density Lipoprotein Cholesterol and the Risk of Cancer: A Mendelian Randomization Study
Benn, M., Tybjærg-Hansen, A., Stender, S., Frikke-Schmidt, R., & Nordestgaard, B. G. (2011) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djr008 · Cited by 167
Metabolomics: Moving to the Clinic
Nordström, A., & Lewensohn, R. (2010) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-009-9156-4 · Cited by 163
Cystatin C and Cardiovascular Disease
van der Laan, S. W., Fall, T., Soumaré, A., Teumer, A., Sedaghat, S., Baumert, J., Zabaneh, D., van Setten, J., Isgum, I., Galesloot, T. E., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.05.092 · Cited by 159
Adiposity as a cause of cardiovascular disease: a Mendelian randomization study
Hägg, S., Fall, T., Ploner, A., Mägi, R., Fischer, K., Draisma, H. H. M., Kals, M., de Vries, P. S., Dehghan, A., Willems, S. M., et al. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyv094 · Cited by 156
† (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00034-0 · Cited by 141
Welsh, P., Polisecki, E., Robertson, M., Jahn, S., Buckley, B. M., de Craen, A. J. M., Ford, I., Jukema, J. W., Macfarlane, P. W., Packard, C. J., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1064 · Cited by 140
Self-citationDavey Smith, G. (2011) · Genes & Nutrition · doi:10.1007/s12263-010-0181-y · Cited by 134
Pfister, R., Sharp, S. J., Luben, R., Welsh, P. I., Barroso, I., Salomaa, V. V., Meirhaeghe, A., Khaw, K., Sattar, N. A., Langenberg, C., et al. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1001112 · Cited by 126
Genetic variation at CHRNA5-CHRNA3-CHRNB4 interacts with smoking status to influence body mass index
Freathy, R. M., Kazeem, G., Morris, R. W., Johnson, P., Paternoster, L., Ebrahim, S. B. J., Hattersley, A. T., Hill, A., Hingorani, A. D., Holst, J. J., et al. (2011) · International Journal of Epidemiology · doi:10.1093/ije/dyr077 · Cited by 126
Self-citationCasas, J. P., Ninio, E., Panayiotou, A. G., Palmen, J., Cooper, J. A., Ricketts, S. L., Sofat, R., Nicolaides, A. N., Corsetti, J. P., Fowkes, F. G. R., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.923383 · Cited by 125
Hernández‐Vargas, H., Castelino, J. M., Silver, M. J., Domínguez-Salas, P., Cros, M., Durand, G., Calvez‐Kelm, F. L., Prentice, A. M., Wild, C. P., Moore, S. E., et al. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyv027 · Cited by 124
Secretory Phospholipase A2-IIA and Cardiovascular Disease
Holmes, M. V., Simon, T., Exeter, H. J., Folkersen, L., Asselbergs, F. W., Guardiola, M., Cooper, J. A., Palmen, J., Hubacek, J. A., Carruthers, K. F., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.06.044 · Cited by 120
Nonfasting Glucose, Ischemic Heart Disease, and Myocardial Infarction
Benn, M., Tybjærg‐Hansen, A., McCarthy, M. I., Jensen, G. B., Grande, P., & Nordestgaard, B. G. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.02.043 · Cited by 115
Strengthening causal inference in cardiovascular epidemiology through Mendelian randomization
Smith, G. D., Timpson, N. J., & Ebrahim, S. B. J. (2008) · Annals of Medicine · doi:10.1080/07853890802010709 · Cited by 114
Self-citationWang, Q., Kangas, A. J., Soininen, P., Tiainen, M., Tynkkynen, T., Puukka, K. S., Ruokonen, A., Viikari, J. S. A., Kähönen, M. A. P., Lehtimäki, T. J., et al. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyv093 · Cited by 110
Pfister, R., Barnes, D. R., Luben, R., Forouhi, N. G., Bochud, M., Khaw, K., Wareham, N. J., & Langenberg, C. (2011) · Diabetologia · doi:10.1007/s00125-011-2235-0 · Cited by 105
Sofat, R., Hingorani, A. D., Smeeth, L., Humphries, S. E., Talmud, P. J., Cooper, J., Shah, T., Sandhu, M. S., Ricketts, S. L., Boekholdt, S. M., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.865444 · Cited by 104
Self-citationUsing Multivariable Mendelian Randomization to Disentangle the Causal Effects of Lipid Fractions
Burgess, S., Freitag, D. F., Khan, H., Gorman, D. N., & Thompson, S. G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108891 · Cited by 96
Self-citationHow Does Body Fat Influence Bone Mass in Childhood? A Mendelian Randomization Approach
Timpson, N. J., Sayers, A. E., Smith, G. D., & Tobias, J. H. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.081109 · Cited by 95
Self-citationWinsløw, U., Rode, L., & Nordestgaard, B. G. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyu276 · Cited by 95
Stender, S., Frikke‐Schmidt, R., Nordestgaard, B. G., Grande, P., & Tybjærg‐Hansen, A. (2012) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2012.02576.x · Cited by 91
Is epidemiology ready for epigenetics?
Relton, C. L., & Smith, G. D. (2012) · International Journal of Epidemiology · doi:10.1093/ije/dys006 · Cited by 87
McArdle, P. F., Whitcomb, B. W., Tanner, K., Mitchell, B. D., Shuldiner, A. R., & Parsa, A. (2012) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-12-16 · Cited by 87
Metabolomics, Pathway Regulation, and Pathway Discovery
Zhang, G., Sadhukhan, S., Tochtrop, G. P., & Brunengraber, H. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.r110.171405 · Cited by 86
Mining the Human Phenome Using Allelic Scores That Index Biological Intermediates
Evans, D. M., Brion, M., Paternoster, L., Kemp, J. P., McMahon, G., Munafo, M. R., Whitfield, J. B., Medland, S. E., Montgomery, G. W., Timpson, N. J., et al. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003919 · Cited by 79
Self-citationBrøndum-Jacobsen, P., Benn, M., Afzal, S., & Nordestgaard, B. G. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyv078 · Cited by 79
A rare variant in APOC3 is associated with plasma triglyceride and VLDL levels in Europeans
Timpson, N. J., Walter, K., Min, J. L., Tachmazidou, I., Malerba, G., Shin, S., Chen, L., Futema, M., Southam, L., Iotchkova, V., et al. (2014) · Nature Communications · doi:10.1038/ncomms5871 · Cited by 77
Self-citationThe causal effect of malaria on stunting: a Mendelian randomization and matching approach
Kang, H., Kreuels, B., Adjei, O., Krumkamp, R., May, J., & Small, D. S. (2013) · International Journal of Epidemiology · doi:10.1093/ije/dyt116 · Cited by 77
Bjørngaard, J. H., Gunnell, D., Elvestad, M. B., Smith, G. D., Skorpen, F., Krokan, H., Vatten, L., & Romundstad, P. (2013) · Psychological Medicine · doi:10.1017/s0033291712001274 · Cited by 71
Self-citationMendelian randomisation applied to drug development in cardiovascular disease: a review
Mokry, L. E., Ahmad, O. S., Forgetta, V., Thanassoulis, G., & Richards, J. B. (2014) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2014-102438 · Cited by 70
Shungin, D., Cornelis, M. C., Divaris, K., Holtfreter, B., Shaffer, J. R., Yu, Y., Barros, S. P., Beck, J. D., Biffar, R., Boerwinkle, E., et al. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyv075 · Cited by 68
Self-citationSilverwood, R. J., Holmes, M. V., Dale, C. E., Lawlor, D. A., Whittaker, J. C., Smith, G. D., Leon, D. A., Palmer, T., Keating, B. J., Zuccolo, L., et al. (2014) · International Journal of Epidemiology · doi:10.1093/ije/dyu187 · Cited by 66
Bergholdt, H. K. M., Nordestgaard, B. G., Varbo, A., & Ellervik, C. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyv109 · Cited by 66
Groom, A., Potter, C., Swan, D., Fatemifar, G., Evans, D. M., Ring, S. M., Turcot, V., Pearce, M. S., Embleton, N. D., Smith, G. D., et al. (2011) · Diabetes · doi:10.2337/db11-1039 · Cited by 61
Capitalizing on Mendelian randomization to assess the effects of treatments
Smith, G. D. (2007) · Journal of the Royal Society of Medicine · doi:10.1258/jrsm.100.9.432 · Cited by 60
Self-citationCapitalizing on Mendelian randomization to assess the effects of treatments
Smith, G. D. (2007) · Journal of the Royal Society of Medicine · doi:10.1177/014107680710000923 · Cited by 60
Smith, G. D. (2011) · Epidemiology · doi:10.1097/ede.0b013e31821d0426 · Cited by 57
Lewis, S. J., Araya, R., Davey Smith, G., Freathy, R., Gunnell, D., Palmer, T., & Munafò, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021689 · Cited by 53
von Hinke, S., Smith, G. D., Lawlor, D. A., Propper, C., & Windmeijer, F. (2012) · Economics & Human Biology · doi:10.1016/j.ehb.2012.04.015 · Cited by 49
Ward, M. E., McMahon, G., Pourcain, B. S., Evans, D. M., Rietveld, C. A., Benjamin, D. J., Koellinger, P., Cesarini, D. A., Smith, G. D., & Timpson, N. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100248 · Cited by 48
Self-citationWang, Y., Zhang, Y., Zhang, J., Tang, X., Qian, Y., Gao, P., & Zhu, D. (2012) · Journal of Human Hypertension · doi:10.1038/jhh.2012.15 · Cited by 47
Quantitative high-throughput metabolomics: a new era in epidemiology and genetics
Ala‐Korpela, M., Kangas, A. J., & Soininen, P. (2012) · Genome Medicine · doi:10.1186/gm335 · Cited by 44
Mendelian randomization: the use of genes in instrumental variable analyses
von Hinke, S., Smith, G. D., Lawlor, D. A., Propper, C., & Windmeijer, F. (2011) · Health Economics · doi:10.1002/hec.1746 · Cited by 40
Drogan, D., Sheldrick, A. J., Schütze, M., Knüppel, S., Andersohn, F., di Giuseppe, R., Herrmann, B., Willich, S. N., Garbe, E., Bergmann, M. M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032176 · Cited by 34
Wium‐Andersen, M. K., Ørsted, D. D., Tolstrup, J. S., & Nordestgaard, B. G. (2014) · International Journal of Epidemiology · doi:10.1093/ije/dyu220 · Cited by 27
Using Mendelian randomization to determine causative factors in cardiovascular disease
Johansen, C. T., & Hegele, R. A. (2012) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2012.02586.x · Cited by 24
Statins and type 2 diabetes: genetic studies on target
Frayling, T. M. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61639-1 · Cited by 24
Shin, S., Petersen, A.-K., Wahl, S., Zhai, G., Römisch‐Margl, W., Small, K. S., Döring, A., Kato, B. S., Peters, A., Grundberg, E., et al. (2014) · Genome Medicine · doi:10.1186/gm542 · Cited by 18
Zhao, J. V., Jiang, C., Lam, T., Liu, B., Cheng, K. K., Xu, L., Long, M. J., Zhang, W., Leung, G. M., & Schooling, C. M. (2014) · International Journal of Epidemiology · doi:10.1093/ije/dyu241 · Cited by 18
Promises and Limitations of Mendelian Randomization for Evaluation of Biomarkers
Glynn, R. J. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2009.142513 · Cited by 17
Ridker, P. M., Paynter, N. P., Danik, J. S., & Glynn, R. J. (2010) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2010.0071 · Cited by 8
Commentary: Mendelian randomization, testosterone, and cardiovascular disease
Gong, J., & Zubair, N. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyv003 · Cited by 1
Cited by
Murray, C. J. L., Aravkin, A. Y., Zheng, P., Abbafati, C., Abbas, K. M., Abbasi-Kangevari, M., Abd-Allah, F., Abdelalim, A., Abdollahi, M., Abdollahpour, I., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30752-2 · Cited by 9,854
Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption
Hartwig, F. P., Davey Smith, G., & Bowden, J. (2017) · International Journal of Epidemiology · doi:10.1093/ije/dyx102 · Cited by 3,485
Mendelian Randomization as an Approach to Assess Causality Using Observational Data
Sekula, P., Del Greco M, F., Pattaro, C., & Köttgen, A. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016010098 · Cited by 2,351
Yavorska, O. O., & Burgess, S. (2017) · International Journal of Epidemiology · doi:10.1093/ije/dyx034 · Cited by 2,052
Self-citationPsychiatric Genomics: An Update and an Agenda
Sullivan, P. F., Agrawal, A., Bulik, C. M., Andreassen, O. A., Børglum, A. D., Breen, G., Cichon, S., Edenberg, H. J., Faraone, S. V., Gelernter, J., et al. (2018) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2017.17030283 · Cited by 676
Metadata
- Authors
- Burgess, S., Timpson, N. J., Ebrahim, S., & Davey Smith, G.
- Venue
- International Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-04-01
- Volume
- 44
- Issue
- 2
- Pages
- 379-388
- ISSN
- 0300-5771 (ISSN-L)
- 1464-3685
- OpenAlex
- W2143685991
- Cited by
- 304
- References
- 117
- FWCI
- 15.01
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.